# Safety Study of Pioglitazone Compared To Glyburide on Liver Function

> **NCT00494312** · PHASE4 · COMPLETED · sponsor: **Takeda** · enrollment: 2120 (actual)

## Conditions studied

- Diabetes Mellitus
- Liver

## Interventions

- **DRUG:** Pioglitazone
- **DRUG:** Glyburide

## Key facts

- **NCT ID:** NCT00494312
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-10
- **Primary completion:** 2005-06
- **Final completion:** 2005-06
- **Target enrollment:** 2120 (ACTUAL)
- **Last updated:** 2012-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00494312

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00494312, "Safety Study of Pioglitazone Compared To Glyburide on Liver Function". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00494312. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*